Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-022548

Chief Financial Officer sold 347 shares at $8.78 ($3,047)

From the SEC's structured data for this filing

Trades in this filing

Trigilio Jeffrey · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-12 Sale : show line 1 in the form −347 $8.78 $3,047 86,940 D
Open-market sales · 347 sh · avg $8.78 · $3,047
Loading xslF345X04/ownership.xml…